Australian Biotechnology News

Wheat right for Proteome

Proteome sells exclusive license to DiagnostIQ test to Bayer CropScience

Sydney's Proteome Systems [ASX: PXL] has sold an exclusive license for its DiagnostIQ test device to Bayer CropScience.

Under the agreement Bayer and Proteome will also collaborate to produce new products based on the technology.

Bayer will own the commercialisation rights for the products, but will pay PXL product developments and license fees as well on royalties on each sale.

Bayer and Proteome have already collaborated to produce WheatRite, a quality assurance test that can be completed in three minutes.

WheatRite will be launched this year, and is initially to be sold in Canada, with expansion to other markets including Australia to occur later.

More about: Bayer, Proteome Systems

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.
Users posting comments agree to the Australian Life Scientist comments policy.
Login or register to link comments to your user profile, or you may also post a comment without being logged in.